MedTrace Logo

Nordic vs Blood Flow Restriction Nordic Exercise in Elite Female Pole Vaulters

NCT07705698 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-07-15

No results posted yet for this study

Summary

The purpose of this randomized controlled trial is to compare the effects of Nordic Hamstring Exercise (NHE) and Blood Flow Restriction-assisted Nordic Hamstring Exercise (BFR-NHE) on hamstring muscle strength, muscle morphology, and functional performance in elite adolescent female pole vaulters. Thirty-six athletes aged 12-18 years will be randomly assigned to a Nordic Hamstring Exercise group, a Blood Flow Restriction-assisted Nordic Hamstring Exercise group, or a control group. Intervention groups will participate in supervised exercise training three times per week for eight weeks, while the control group will continue routine sports training. Outcomes will be assessed before and after the intervention period.

Conditions

  • Muscle Strength
  • Athletic Performance
  • Hamstring Adaptation
  • Sports Injury Prevention

Interventions

BEHAVIORAL

Nordic Hamstring Exercise

Participants will perform a supervised Nordic Hamstring Exercise program three times per week for 8 weeks in addition to their routine pole vault training. The exercise program will be progressively increased according to participant tolerance and training progression.

BEHAVIORAL

Blood Flow Restriction-Assisted Nordic Hamstring Exercise

articipants will perform a supervised Nordic Hamstring Exercise program combined with individualized blood flow restriction training three times per week for 8 weeks in addition to their routine pole vault training. Blood flow restriction will be applied using pneumatic cuffs at a predetermined percentage of arterial occlusion pressure.

Sponsors & Collaborators

  • Toros University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-27
Primary Completion
2027-03-31
Completion
2027-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07705698 on ClinicalTrials.gov